Valeant Pharmaceuticals International, Inc. (BHC)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drug Delivery

Drugs

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

64

0

0

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
01-Oct-24 4:17 PM View:	30-Sep-24 Grant $6.87K	Wechsler Amy B Director		Valeant Pharmaceuticals International, Inc. - BHC	0% 206.25K to 207.09K	0	0	--	--	Show Txns Hide Txns

01-Oct-24 4:15 PM View:	30-Sep-24 Grant $62.50K	Paulson John Director		Valeant Pharmaceuticals International, Inc. - BHC	3% 252.64K to 260.3K	0	0	--	--	Show Txns Hide Txns

01-Oct-24 4:16 PM View:	30-Sep-24 Grant $33.12K	Icahn Brett Director		Valeant Pharmaceuticals International, Inc. - BHC	3% 148.61K to 152.67K	0	0	--	--	Show Txns Hide Txns

03-Sep-24 4:21 PM View:	30-Aug-24 Payment of Exercise ($87.07K)	Appio Thomas Chief Executive Officer Director		Valeant Pharmaceuticals International, Inc. - BHC	(1%) 1.37M to 1.35M	0	0	--	--	Show Txns Hide Txns

09-Sep-24 4:54 PM View:	06-Sep-24 Sale (Planned) ($83.03K)	Carson Seana EVP, General Counsel		Valeant Pharmaceuticals International, Inc. - BHC	(13%) 499.9K to 435.2K	0	0	--	--	Show Txns Hide Txns

09-Sep-24 4:37 PM View:	05-Sep-24 Payment of Exercise ($24.65K)	Barresi John S SVP, Controller & CAO		Valeant Pharmaceuticals International, Inc. - BHC	(3%) 154.39K to 150.41K	0	0	--	--	Show Txns Hide Txns